Literature DB >> 21955941

Synthesis of lipids for development of multifunctional lipid-based drug-carriers.

Guodong Zhu1, Yahya Alhamhoom, Brian S Cummings, Robert D Arnold.   

Abstract

A simple approach to synthesize phospholipids to modulate drug release and track lipid-based particulate drug-carriers is described. We synthesized two ether lipids, 1 1-O-hexadecyl-2-pentadenoyl-sn-glycerol-3-phosphocholine (C(31)PC) and 2 1-O-hexadecyl-2-pentadenoyl-sn-glycerol-3-phosphomethanol (C(31)PM), and examined their ability to alter enzymatically triggered release of 6-carboxyfluorescein from liposomes incubated in TRIS buffer or fetal bovine serum solutions. Further, we demonstrated that odd-chain lipids, for example, C(31)PC, could be identified in rat plasma without interference of endogenous lipids. This approach can be adapted to synthesize a variety of lipids for use in developing and optimizing multifunctional drug-carriers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955941      PMCID: PMC3195505          DOI: 10.1016/j.bmcl.2011.08.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  29 in total

Review 1.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Authors:  D C Drummond; O Meyer; K Hong; D B Kirpotin; D Papahadjopoulos
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

Review 2.  Phototriggering of liposomal drug delivery systems.

Authors:  P Shum; J M Kim; D H Thompson
Journal:  Adv Drug Deliv Rev       Date:  2001-12-31       Impact factor: 15.470

3.  Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.

Authors:  J R Graff; B W Konicek; J A Deddens; M Chedid; B M Hurst; B Colligan; B L Neubauer; H W Carter; J H Carter
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

4.  Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.

Authors:  G Kong; G Anyarambhatla; W P Petros; R D Braun; O M Colvin; D Needham; M W Dewhirst
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

5.  Photoinitiated destabilization of sterically stabilized liposomes.

Authors:  B Bondurant; A Mueller; D F O'Brien
Journal:  Biochim Biophys Acta       Date:  2001-03-09

6.  Secretory phospholipase A₂ responsive liposomes.

Authors:  Guodong Zhu; Jason N Mock; Ibrahim Aljuffali; Brian S Cummings; Robert D Arnold
Journal:  J Pharm Sci       Date:  2011-03-31       Impact factor: 3.534

Review 7.  Phospholipase A(2)s in cell injury and death.

Authors:  B S Cummings; J McHowat; R G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

8.  Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

Authors:  Jiazhong Jiang; Blake Lee Neubauer; Jeremy R Graff; Marcio Chedid; James E Thomas; Neal W Roehm; Shaobo Zhang; George J Eckert; Michael O Koch; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

9.  Drug delivery by phospholipase A(2) degradable liposomes.

Authors:  J Davidsen; C Vermehren; S Frokjaer; O G Mouritsen; K Jørgensen
Journal:  Int J Pharm       Date:  2001-02-19       Impact factor: 5.875

10.  Rapid release of liposomal contents upon photoinitiated destabilization with UV exposure.

Authors:  Tony Spratt; Bruce Bondurant; David F O'Brien
Journal:  Biochim Biophys Acta       Date:  2003-04-01
View more
  5 in total

1.  Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.

Authors:  Jeong Yeon Kang; Mathew Eggert; Shravanthi Mouli; Ibrahim Aljuffali; Xiaoyu Fu; Ben Nie; Amy Sheil; Kendall Waddey; Charlie D Oldham; Sheldon W May; Rajesh Amin; Robert D Arnold
Journal:  Pharm Res       Date:  2014-08-27       Impact factor: 4.200

Review 2.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

Review 3.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Authors:  Nhat D Quach; Robert D Arnold; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2014-06-04       Impact factor: 5.858

4.  Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.

Authors:  J N Mock; L J Costyn; S L Wilding; R D Arnold; B S Cummings
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

5.  Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.

Authors:  N D Quach; J N Mock; N E Scholpa; M W Eggert; C Payré; G Lambeau; R D Arnold; B S Cummings
Journal:  Mol Pharm       Date:  2014-09-22       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.